SFP
ACHN

Santa Fe Partners’s Achillion Pharmaceuticals ACHN Stock Holding History

Santa Fe Partners’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-69,582
Closed -$751K – 368
2015
Q4 		$751K Sell
69,582
-6,958
-9% -$63.3K 0.12% 285
2015
Q3 		$530K Sell
76,540
-2,164
-3% -$17.6K 0.07% 343
2015
Q2 		$697K Sell
78,704
-7,648
-9% -$72.3K 0.1% 336
2015
Q1 		$851K Sell
86,352
-18,813
-18% -$235K 0.1% 326
2014
Q4 		$1.29M Buy
105,165
+55,024
+110% +$672K 0.16% 258
2014
Q3 		$501K Buy
+50,141
New +$465K 0.08% 383

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Santa Fe Partners's ACHN Position: Q1 2016 in Review

Santa Fe Partners sold out of Achillion Pharmaceuticals (ACHN) in Q1 2016, closing a stake of 69,582 shares — an estimated $751K sold.

Santa Fe Partners first reported a position in ACHN in Q3 2014 and held it in 6 quarters. The position peaked at $1.29M in Q4 2014. 153 funds tracked by Wall St. Rank hold ACHN as of Q1 2016.

  • Santa Fe Partners reported no remaining Achillion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 69,582 Achillion Pharmaceuticals shares in Q1 2016, an estimated $751K.
  • Santa Fe Partners first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Santa Fe Partners's Achillion Pharmaceuticals position peaked at $1.29M in Q4 2014.
  • 153 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.